Tim Eisen
机构：University of Cambridge, Cambridge School · ORCID：0000-0001-9663-4873
发表论文 259 篇 · 总被引 18628 次 · h-index 57
代表论文
- Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma (2024 · Neoplasia · 被引 3)
- Vasculo-immune modulatory effects of anti-VEGF therapy in metastatic clear cell renal cell carcinoma: The A-PREDICT trial. (2025 · Journal of Clinical Oncology · 被引 2)
- Establishing the China–UK Cancer Prevention and Control Alliance (2025 · The Lancet Oncology · 被引 1)
- Figure 2 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma (2026)
- Supplementary Table 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma (2026)
- Figure 3 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma (2026)